Accelerate biotechnology

Meet the experts

    Challenges in virus-based manufacturing in GMP
    Meet the Expert: Marije, GMP Scientist Many customers want to know how much time it will take to move a candidate viral vaccine or viral vector product from bench to bed and what shortcuts can be taken in order to move even faster. Having strong pre-clinical data from in vivo experiments showing…

    Analytical assay development: go ALL the way
    Meet the Expert: Gert, Analytical Assay Scientist The truth is; the accuracy and robustness of any process under development or manufacturing outcome is only as good as the reliability of the assays needed to understand the process. The effort involved to get to a comfortable situation where all necessary tests are available,…

    Latest advancements in bioprocess intensification for efficient biopharmaceutical production
    Meet the Expert: Ahd, Bioprocess Project Director Current costs of biopharmaceutical manufacturing often prevent segments of the world’s population from accessing critical medicines or even prevent medicines from being marketed. A significant part of these costs come from the need for large and expensive manufacturing facilities. This hurdle can be overcome by…

    In manufacturing it’s ALL about Quality Control
    Meet the Expert: Freek, Quality Control / Validation Scientist The Quality Control (QC) department performs analytical development, assay qualification, assay validation, testing on raw materials, cell substrates and cell banks. Also, the department is heavily involved in the “in-process” testing as well as testing the final drug substance and drug product. In…

    Drivers in selecting a reliable partner for clinical GMP manufacturing
    Meet the Expert: Pim, GMP Scientist One of the most sought-after outsourcing demands in life sciences is clinical GMP manufacturing and release of biopharmaceutical products to allow subsequent testing in human subjects for safety and efficacy. Globally the market for this outsourcing activity is estimated at about $3 billion annually, of which…

    Quality specialist is key in any biopharmaceutical development team
    Meet the Expert: Margreet, QA specialist The ability to translate biopharmaceutical research into products is known to have a high failure rate. A staggering 75% of published pre-clinical data cannot be reproduced or validated to allow further product development1. I believe that the only way to prevent such disappointments both scientifically, as…

    Novel HPLC assays allow for better biopharmaceutical development
    Meet the expert: Rinske, Associate Director Analytical Assays. HPLC has been widely used for decades in the analysis of small molecules and is gaining momentum as an important tool for analyzing biotechnology products. For instance, HPLC has been successfully introduced for the analysis of monoclonal antibody-based products and is more and more…

    How to scale your adherent cell culture
    Meet the expert: Matthijs, Bioprocess Scientist. Cells derived from mammalian species and cultured under artificial laboratory conditions have been used to produce complex biological products. As such cells normally grow as a tissue, most available artificial mammalian cells are originally surface-dependent and therefore are called adherent cells. Adherent cells will only duplicate…

Batavia Biosciences B.V.

Bioscience Park Leiden
Zernikedreef 16 2333 CL Leiden
The Netherlands

e: info@bataviabiosciences.com
t: +31 (0) 88 9950600

Batavia Biosciences Inc.

300 TradeCenter Suite 6650
Woburn MA01801
United States of America

e: info@bataviabiosciences.com
t: +1 (0) 781 305 3921

Batavia Biosciences HKG

Room 1206, 397 Hennessy Road
Wanchai
Hong Kong

e: info@bataviabiosciences.com
t: +852 (0) 3102 6861
Intellectual and other property rights to the information contained in this site are held by Batavia Biosciences B.V. with all right reserved © 2019